Home » EPIC Archives: AVCT

AVCT News Archives

The Next Wave of Immuno-Oncology

Avacta Group Plc

In 2017, the first immuno-oncology cell therapies, known as chimeric antigen receptor T cells, or CAR T, were approved by the U.S. Food and Drug Administration. Immuno-oncology cell therapy is ...

Read Article »

BIO International Convention

Avacta Group Plc

Over 18,000 leaders in Biotech and Pharma attended the 2018 BIO convention. This year the Avacta team will be exhibiting and will be found on booth 3559. Further information about ...

Read Article »

Antibody Mimetics

Avacta Group Plc

“The sad fact is that around 70% of cancer patients with solid based tumors don’t respond to classical chemotherapy,” said Joseph Tabernero, MD, PhD, head of Val d’Hebron Institute of ...

Read Article »